Drug Developers Making Strides in Streamlining Patient Recruitment and Retention
Published on:
Applied Clinical Trials
According to a new study from the Tufts Center for the Study of Drug Development efforts by drug developers during the last decade to improve recruitment and retention appear to be paying off. Enrollment timelines now are equal to or shorter than planned timelines in 77% of studies, while a previous study in 2012 found that a high percentage of clinical trials had to extend planned timelines to achieve target enrollment.
